In this highlight video from the second episode of PwC Presents BT MindRush Pods, Siddharth Zarabi, Editor, Business Today ... and innovations in advancing biotechnology through the development ...

Trinity Biotech has a 12-month ... the clinical laboratory and point-of-care (POC) segments of the diagnostic market in the Americas and Ireland. The company offers clinical laboratory products ...

Earnings Per Share (TTM) A company's net income for the trailing twelve month period expressed as a dollar amount per fully diluted shares outstanding. Market Capitalization Reflects the total ...

Stocks: Real-time U.S. stock quotes reflect trades reported through Nasdaq only; comprehensive quotes and volume reflect trading in all markets and are delayed at least 15 minutes. International ...

“With so many company presentations, a robust Seed Showcase, and a new program track, TechBio, Biotech Showcase has become the number one destination of choice for both innovators and private ...

The company is known for pioneering DNA sequencing. Chris Smith, CEO of oncology diagnostic company NeoGenomics Inc., is getting a seat on the board of Pacific Biosciences of California Inc ...

Trinity Biotech plc (NASDAQ:TRIB), an Ireland-based diagnostic company with a market capitalization of $23.7 million and current trading price of $1.32, is evaluating the potential effects of a recent ...

This is the foundation of Wellbeing International Foundation’s approach, where the science of natural healing is enhanced through cutting-edge biotech. One of the most promising innovations in this ...

Trinity Biotech is now poised to pursue further clinical trials and aims to file for regulatory approval in the European Union in 2025, followed by U.S. FDA approval in 2026. These steps are crucial ...